Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Myriad Genetics, |
RCV002306739 | SCV002602769 | likely pathogenic | Carnitine palmitoyl transferase II deficiency, severe infantile form; Carnitine palmitoyl transferase II deficiency, myopathic form; Carnitine palmitoyl transferase II deficiency, neonatal form | 2022-01-31 | criteria provided, single submitter | clinical testing | NM_000098.2(CPT2):c.150delC(R51Gfs*22) is expected to be pathogenic in the context of carnitine palmitoyltransferase II deficiency. This variant is predicted to lead to an abnormal or absent protein product due to the creation of a premature termination codon in CPT2, a gene where loss-of-function variants are known to be pathogenic. Please note: this variant was assessed in the context of healthy population screening. |